First results of the NOGGO PERCEPTION: Phase II investigational study of pembrolizumab in combination with chemotherapy in platinum-sensitive recurrent low-grade serous ovarian cancer.
Authors: Jacek P. Grabowski, Elena Ioana Braicu, Philipp Harter, Dario Zocholl, Lea-Jean Pietzke, Florian Heitz, Tjadina Arndt, Julia Welz, Jalid Sehouli